Status:
UNKNOWN
The Effect of Hormonal Contraception on Female
Lead Sponsor:
Lithuanian University of Health Sciences
Conditions:
Adverse Effect of Oral Contraceptives, Initial Encounter
Eligibility:
FEMALE
18-40 years
Brief Summary
The aim- To evaluate the impact of combined oral contraceptives on women's psychosexual, metabolic, blood coagulation, hormonal and genetic measures. Combined oral contraceptives (COCs) is still the ...
Detailed Description
The aim To evaluate the impact of combined oral contraceptives on women's psychosexual, metabolic, blood coagulation, hormonal and genetic measures. The objectives 1. To asses the relation of AR po...
Eligibility Criteria
Inclusion
- 18 - 40 years old women applying to obstetrician-gynaecologist for contraception use or for preventive health care and giving their consent to participate in the study (who signed The Informed Consent Form) will be eligible to participate in the study. It is important to note that these women should not have underlying medical conditions (chronic non - infection diseases, chronic or acute infection diseases).
- Not using hormonal contraception for 6 months or more.
Exclusion
- Women applying for obstetrician-gynaecologist consultation on gynaecological pathology.
- Women with underlying medical conditions (chronic non - infection diseases, chronic or acute infection diseases).
- Women, planning to get pregnant during the 12 months.
- Pregnant women (suspected or confirmed pregnancy).
Key Trial Info
Start Date :
February 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2016
Estimated Enrollment :
340 Patients enrolled
Trial Details
Trial ID
NCT01852786
Start Date
February 1 2013
End Date
February 1 2016
Last Update
May 14 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lithuanian University of Health Sciences
Kaunas, Lithuania, LT- 50009